Charles J Lowenstein

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Genome Wide Association

Randomized Controlled Trial

Cardiovascular Risk Factors

Coronary Artery Bypass Grafting

Top Venues

Annals of internal medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Marios Arvanitis, Charles J Lowenstein
Dyslipidemia. Annals of internal medicine (2023)
Scott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, Alexander Peikert, Orly Vardeny, Mikhail Naum Kosiborod, Jeffrey S Berger, Harmony R Reynolds, Stephanie Mavromichalis, Anya Barytol, Andrew D Althouse, James F Luther, Eric S Leifer, Andrei L Kindzelski, Andrea N Edginton, Michelle Ng Gong, Lucy Z Kornblith, Pooja Khatri, Keri S Kim, Lisa Baumann Kreuziger, Lana Wahid, Bridget-Anne Kirwan, Mark W Geraci, Matthew D Neal, Judith S Hochman, null null
Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial. Circulation (2023)
J Allen Bennett, Michael A Mastrangelo, Sara K Ture, Charles O Smith, Shannon G Loelius, Rachel A Berg, Xu Shi, Ryan M Burke, Sherry L Spinelli, Scott J Cameron, Thomas E Carey, Paul S Brookes, Robert E Gerszten, Maria Sabater-Lleal, Paul S de Vries, Jennifer E Huffman, Nicholas L Smith, Craig N Morrell, Charles J Lowenstein
The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function. Nature communications 11 (1) (2020)
Charles J Lowenstein
VAMP-3 mediates platelet endocytosis. Blood 130 (26) (2018)